United States Cold, Allergy, and Sinus Tablet Market Report 2016

Publisher Name :
Date: 12-Oct-2016
No. of pages: 121
Inquire Before Buying

Notes:

Sales, means the sales volume of Cold, Allergy, and Sinus Tablet

Revenue, means the sales value of Cold, Allergy, and Sinus Tablet

This report studies sales (consumption) of Cold, Allergy, and Sinus Tablet in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Private Lable

- McNeil Nutritionals

- Reckitt Benckiser

- MSD Consumer Care

- Chattem

- Bayer

- Procter & Gamble

- Johnson & Johnson

- Pfizer

- Novaritis Consurmer

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Cold, Allergy, and Sinus Tablet in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Cold, Allergy, and Sinus Tablet Market Report 2016

Table of Contents
United States Cold, Allergy, and Sinus Tablet Market Report 2016
1 Cold, Allergy, and Sinus Tablet Overview
1.1 Product Overview and Scope of Cold, Allergy, and Sinus Tablet
1.2 Classification of Cold, Allergy, and Sinus Tablet
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Cold, Allergy, and Sinus Tablet
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Cold, Allergy, and Sinus Tablet (2011-2021)
1.4.1 United States Cold, Allergy, and Sinus Tablet Sales and Growth Rate (2011-2021)
1.4.2 United States Cold, Allergy, and Sinus Tablet Revenue and Growth Rate (2011-2021)
2 United States Cold, Allergy, and Sinus Tablet Competition by Manufacturers
2.1 United States Cold, Allergy, and Sinus Tablet Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Cold, Allergy, and Sinus Tablet Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Cold, Allergy, and Sinus Tablet Average Price by Manufactures (2015 and 2016)
2.4 Cold, Allergy, and Sinus Tablet Market Competitive Situation and Trends
2.4.1 Cold, Allergy, and Sinus Tablet Market Concentration Rate
2.4.2 Cold, Allergy, and Sinus Tablet Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Cold, Allergy, and Sinus Tablet Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Cold, Allergy, and Sinus Tablet Sales and Market Share by Type (2011-2016)
3.2 United States Cold, Allergy, and Sinus Tablet Revenue and Market Share by Type (2011-2016)
3.3 United States Cold, Allergy, and Sinus Tablet Price by Type (2011-2016)
3.4 United States Cold, Allergy, and Sinus Tablet Sales Growth Rate by Type (2011-2016)
4 United States Cold, Allergy, and Sinus Tablet Sales (Volume) by Application (2011-2016)
4.1 United States Cold, Allergy, and Sinus Tablet Sales and Market Share by Application (2011-2016)
4.2 United States Cold, Allergy, and Sinus Tablet Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Cold, Allergy, and Sinus Tablet Manufacturers Profiles/Analysis
5.1 Private Lable
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Cold, Allergy, and Sinus Tablet Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Private Lable Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 McNeil Nutritionals
5.2.2 Cold, Allergy, and Sinus Tablet Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 McNeil Nutritionals Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Reckitt Benckiser
5.3.2 Cold, Allergy, and Sinus Tablet Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Reckitt Benckiser Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 MSD Consumer Care
5.4.2 Cold, Allergy, and Sinus Tablet Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 MSD Consumer Care Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Chattem
5.5.2 Cold, Allergy, and Sinus Tablet Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Chattem Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Bayer
5.6.2 Cold, Allergy, and Sinus Tablet Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Bayer Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Procter & Gamble
5.7.2 Cold, Allergy, and Sinus Tablet Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Procter & Gamble Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Johnson & Johnson
5.8.2 Cold, Allergy, and Sinus Tablet Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Johnson & Johnson Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Pfizer
5.9.2 Cold, Allergy, and Sinus Tablet Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Pfizer Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Novaritis Consurmer
5.10.2 Cold, Allergy, and Sinus Tablet Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Novaritis Consurmer Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
6 Cold, Allergy, and Sinus Tablet Manufacturing Cost Analysis
6.1 Cold, Allergy, and Sinus Tablet Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Cold, Allergy, and Sinus Tablet
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Cold, Allergy, and Sinus Tablet Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Cold, Allergy, and Sinus Tablet Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Cold, Allergy, and Sinus Tablet Market Forecast (2016-2021)
10.1 United States Cold, Allergy, and Sinus Tablet Sales, Revenue Forecast (2016-2021)
10.2 United States Cold, Allergy, and Sinus Tablet Sales Forecast by Type (2016-2021)
10.3 United States Cold, Allergy, and Sinus Tablet Sales Forecast by Application (2016-2021)
10.4 Cold, Allergy, and Sinus Tablet Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Cold, Allergy, and Sinus Tablet
Table Classification of Cold, Allergy, and Sinus Tablet
Figure United States Sales Market Share of Cold, Allergy, and Sinus Tablet by Type in 2015
Table Application of Cold, Allergy, and Sinus Tablet
Figure United States Sales Market Share of Cold, Allergy, and Sinus Tablet by Application in 2015
Figure United States Cold, Allergy, and Sinus Tablet Sales and Growth Rate (2011-2021)
Figure United States Cold, Allergy, and Sinus Tablet Revenue and Growth Rate (2011-2021)
Table United States Cold, Allergy, and Sinus Tablet Sales of Key Manufacturers (2015 and 2016)
Table United States Cold, Allergy, and Sinus Tablet Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cold, Allergy, and Sinus Tablet Sales Share by Manufacturers
Figure 2016 Cold, Allergy, and Sinus Tablet Sales Share by Manufacturers
Table United States Cold, Allergy, and Sinus Tablet Revenue by Manufacturers (2015 and 2016)
Table United States Cold, Allergy, and Sinus Tablet Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cold, Allergy, and Sinus Tablet Revenue Share by Manufacturers
Table 2016 United States Cold, Allergy, and Sinus Tablet Revenue Share by Manufacturers
Table United States Market Cold, Allergy, and Sinus Tablet Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cold, Allergy, and Sinus Tablet Average Price of Key Manufacturers in 2015
Figure Cold, Allergy, and Sinus Tablet Market Share of Top 3 Manufacturers
Figure Cold, Allergy, and Sinus Tablet Market Share of Top 5 Manufacturers
Table United States Cold, Allergy, and Sinus Tablet Sales by Type (2011-2016)
Table United States Cold, Allergy, and Sinus Tablet Sales Share by Type (2011-2016)
Figure United States Cold, Allergy, and Sinus Tablet Sales Market Share by Type in 2015
Table United States Cold, Allergy, and Sinus Tablet Revenue and Market Share by Type (2011-2016)
Table United States Cold, Allergy, and Sinus Tablet Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cold, Allergy, and Sinus Tablet by Type (2011-2016)
Table United States Cold, Allergy, and Sinus Tablet Price by Type (2011-2016)
Figure United States Cold, Allergy, and Sinus Tablet Sales Growth Rate by Type (2011-2016)
Table United States Cold, Allergy, and Sinus Tablet Sales by Application (2011-2016)
Table United States Cold, Allergy, and Sinus Tablet Sales Market Share by Application (2011-2016)
Figure United States Cold, Allergy, and Sinus Tablet Sales Market Share by Application in 2015
Table United States Cold, Allergy, and Sinus Tablet Sales Growth Rate by Application (2011-2016)
Figure United States Cold, Allergy, and Sinus Tablet Sales Growth Rate by Application (2011-2016)
Table Private Lable Basic Information List
Table Private Lable Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Private Lable Cold, Allergy, and Sinus Tablet Sales Market Share (2011-2016)
Table McNeil Nutritionals Basic Information List
Table McNeil Nutritionals Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
Table McNeil Nutritionals Cold, Allergy, and Sinus Tablet Sales Market Share (2011-2016)
Table Reckitt Benckiser Basic Information List
Table Reckitt Benckiser Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
Table Reckitt Benckiser Cold, Allergy, and Sinus Tablet Sales Market Share (2011-2016)
Table MSD Consumer Care Basic Information List
Table MSD Consumer Care Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
Table MSD Consumer Care Cold, Allergy, and Sinus Tablet Sales Market Share (2011-2016)
Table Chattem Basic Information List
Table Chattem Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
Table Chattem Cold, Allergy, and Sinus Tablet Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Cold, Allergy, and Sinus Tablet Sales Market Share (2011-2016)
Table Procter & Gamble Basic Information List
Table Procter & Gamble Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
Table Procter & Gamble Cold, Allergy, and Sinus Tablet Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Cold, Allergy, and Sinus Tablet Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Cold, Allergy, and Sinus Tablet Sales Market Share (2011-2016)
Table Novaritis Consurmer Basic Information List
Table Novaritis Consurmer Cold, Allergy, and Sinus Tablet Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novaritis Consurmer Cold, Allergy, and Sinus Tablet Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cold, Allergy, and Sinus Tablet
Figure Manufacturing Process Analysis of Cold, Allergy, and Sinus Tablet
Figure Cold, Allergy, and Sinus Tablet Industrial Chain Analysis
Table Raw Materials Sources of Cold, Allergy, and Sinus Tablet Major Manufacturers in 2015
Table Major Buyers of Cold, Allergy, and Sinus Tablet
Table Distributors/Traders List
Figure United States Cold, Allergy, and Sinus Tablet Production and Growth Rate Forecast (2016-2021)
Figure United States Cold, Allergy, and Sinus Tablet Revenue and Growth Rate Forecast (2016-2021)
Table United States Cold, Allergy, and Sinus Tablet Production Forecast by Type (2016-2021)
Table United States Cold, Allergy, and Sinus Tablet Consumption Forecast by Application (2016-2021)
  • EMEA (Europe, Middle East and Africa) Recombinant Peptides Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 100
    In this report, the EMEA Recombinant Peptides market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Recombinant Peptides for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux;......
  • EMEA (Europe, Middle East and Africa) Oxyclozanide Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 103
    In this report, the EMEA Oxyclozanide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Oxyclozanide for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Middle Ea......
  • EMEA (Europe, Middle East and Africa) Montelukast Sodium Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 111
    In this report, the EMEA Montelukast Sodium market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Montelukast Sodium for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; ......
  • EMEA (Europe, Middle East and Africa) DHA Powder Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 114
    In this report, the EMEA DHA Powder market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of DHA Powder for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Middle East......
  • United States Active Pharma Ingredient Market Report 2017
    Published: 24-Mar-2017        Price: US 3800 Onwards        Pages: 117
    In this report, the United States Active Pharma Ingredient market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth......
  • United States Pharmaceutical Grade Fulvic Acid Market Report 2017
    Published: 24-Mar-2017        Price: US 3800 Onwards        Pages: 99
    In this report, the United States Pharmaceutical Grade Fulvic Acid market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share an......
  • Global Ketoprofen Sales Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 107
    In this report, the global Ketoprofen market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Ketoprofen for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - South......
  • Global Kaempferol Sales Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 103
    In this report, the global Kaempferol market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Kaempferol for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - Southeas......
  • Global Enzyme Inhibitor Sales Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 100
    In this report, the global Enzyme Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Enzyme Inhibitor for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs